[Rifomycin levels in the lung and tuberculous lesions in man]
[Article in
French]
- PMID: 5371667
Item in Clipboard
[Rifomycin levels in the lung and tuberculous lesions in man]
[Article in
French]
Acta Tuberc Pneumol Belg.
1969.
No abstract available
Similar articles
-
[Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].Ann Ist Carlo Forlanini. 1968;28(2):126-41. Ann Ist Carlo Forlanini. 1968. PMID: 5735705 Italian. No abstract available.
-
[Resumption of treatment by rifomycin of resistant cases of pulmonary tuberculosis].Acta Tuberc Pneumol Belg. 1969;60(3):501-6. Acta Tuberc Pneumol Belg. 1969. PMID: 5371674 French. No abstract available.
-
[Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].Acta Tuberc Pneumol Belg. 1969;60(3):545-53. Acta Tuberc Pneumol Belg. 1969. PMID: 5371679 French. No abstract available.
-
[Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].Acta Tuberc Pneumol Belg. 1969;60(3):521-6. Acta Tuberc Pneumol Belg. 1969. PMID: 5371677 French. No abstract available.
-
[Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].Hoja Tisiol. 1970;27(1):98-117. Hoja Tisiol. 1970. PMID: 5524669 Spanish. No abstract available.
Cited by
-
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.Nat Rev Microbiol. 2009 Dec;7(12):845-55. doi: 10.1038/nrmicro2236. Epub 2009 Oct 26. Nat Rev Microbiol. 2009. PMID: 19855401 Free PMC article. Review.
-
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.Bioorg Med Chem Lett. 2013 Sep 1;23(17):4741-50. doi: 10.1016/j.bmcl.2013.07.006. Epub 2013 Jul 12. Bioorg Med Chem Lett. 2013. PMID: 23910985 Free PMC article. Review.
-
[Results of chemotherapy in tuberculosis].Pneumonologie. 1971;145:305-23. doi: 10.1007/BF02095045. Pneumonologie. 1971. PMID: 4108482 Review. German. No abstract available.
-
Advances in Drug Discovery and Development for Pediatric Tuberculosis.Mini Rev Med Chem. 2016;16(6):481-97. doi: 10.2174/1389557515666150722101723. Mini Rev Med Chem. 2016. PMID: 26202201 Free PMC article. Review.
-
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.Curr Clin Pharmacol. 2010 May;5(2):96-114. doi: 10.2174/157488410791110797. Curr Clin Pharmacol. 2010. PMID: 20156156 Free PMC article. Review.